Thursday, April 9, 2009

Cell Biosciences Gets $10M

Palo Alto-based Cell Biosciences, a developer of instrumentation systems for the life science industry, announced Thursday that the firm has raised $10M in a Series C round. The round was led by the Wellcome Trust, and also included prior investors Domain Associates, Latterell Venture Partners, Novo A/S, Mitsui Ventures, Royal Bank of Canada and The Vertical Group. Cell Biosciences is developing a nanofluidic, immunoassay systems used to analyze proteins in very small biological samples. More information »